Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression
Maria Gałuszko‐węgielnik, Zuzanna Chmielewska, Katarzyna Jakuszkowiak‐wojten, Mariusz S. Wiglusz, Wiesław Jerzy Cubała
Brain Sciences January 13, 2023 Peer reviewed DOI: 10.3390/brainsci13010142 via OpenAlex
Summary
Ketamine may provide benefits for individuals with treatment-resistant depression that includes psychotic features, as shown in a study of four inpatients treated with 0.5 mg/kg intravenous infusions. All patients experienced stable remission and no worsening of psychotic symptoms during both short and long-term follow-up, with one patient showing an immediate reduction in suicidal thoughts. This suggests ketamine's potential as an effective add-on treatment for this challenging condition.
Study at a glance
| Sample size | 4 |
|---|---|
| Population | inpatients suffering from treatment-resistant depression with psychotic features |
| Key finding | Ketamine treatment resulted in stable remission and no exacerbation of psychotic symptoms in all four patients. |
Abstract
Psychotic treatment-resistant depression is a complex and challenging manifestation of mood disorders in the clinical setting. Psychotic depression is a subtype of major depressive disorder characterized by mood-consistent hallucinations and/or delusions. Psychotic depression is often underdiagnosed and undertreated. Ketamine appears to have rapid and potent antidepressant effects in clinical studies, and the Federal Drug Agency approved the use of ketamine enantiomer esketamine-nasal spray for treatment-resistant depression pharmacotherapy in 2019. This study aimed to assess the usage of ketamine for major depressive disorder with psychotic features as an add-on treatment to the standard of care. Here we present four inpatients suffering from treatment-resistant depression with psychotic features, including one with severe suicidal crisis, all treated with 0.5 mg/kg intravenous infusion of ketamine. Subsequent monitoring revealed no exacerbation of psychotic symptoms in short and long-term observation, while stable remission was observed in all cases with imminent antisuicidal effect. Results suggest ketamine may benefit individuals with treatment-resistant depression with psychotic features.